VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 127 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,363 | -32.3% | 16,821 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $192,600 | +69.5% | 16,821 | +58.0% | 0.00% | 0.0% |
| Q3 2020 | $113,625 | -15.5% | 10,649 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $134,390 | +37.9% | 10,649 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $97,438 | -34.4% | 10,649 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $148,554 | -18.9% | 10,649 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $183,269 | -36.8% | 10,649 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $289,866 | +42.2% | 10,649 | 0.0% | 0.00% | +50.0% |
| Q1 2019 | $203,822 | +103.6% | 10,649 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $100,101 | -50.3% | 10,649 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $201,479 | -3.1% | 10,649 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $208,000 | +44.4% | 10,649 | +38.6% | 0.00% | 0.0% |
| Q1 2018 | $144,000 | +12.5% | 7,685 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $128,000 | – | 7,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |